The Role of Oxytocin in Early Life Adversity and Later Psychopathology: a Review of Preclinical and Clinical Studies
- 81 Downloads
Oxytocin is a peptide hormone integral in parturition and milk let-down, and is increasingly recognized as an important regulator of human social behaviors including bonding, trust, fear, and stress. There is an increasing evidence that oxytocin is intricately involved in a broad array of neurophysiological functions and may be a common system implicated in multiple psychiatric disorders. This review examines the putative role of oxytocin in early life adversity-mediated risk for later development of subtypes of psychiatric conditions. Several lines of evidence are reviewed including oxytocin levels, response to exogenous oxytocin administration, and genetic studies.
To date, most studies report lower levels of peripheral and central oxytocin in a dose-response manner in adults exposed to early life adversity. Individuals exposed to early life adversity seem to have a differential response to exogenous oxytocin administration, sometimes with negative outcomes. Several polymorphisms in the oxytocin receptor and emerging epigenetic studies point to a link between oxytocinergic systems and psychiatric disorders.
Specific limitations of the studies in the field are highlighted, and areas for future research are described. Considerably more research is needed to understand the complex role of the oxytocin system in early life adversity and its consequences.
KeywordsOxytocin Early life adversity Depression Anxiety Trauma Parenting
Compliance with ethical standards
Conflict of interest
Dr. Londono Tobon has nothing to disclose.
Dr. Newport has received research support from Eli Lilly, Glaxo SmithKline (GSK), Janssen, National Alliance for Research on Schizophrenia and Depression (NARSAD), National Institutes of Health (NIH), Takeda Pharmaceuticals, and Wyeth. He has served on speakers’ bureaus and/or received honoraria from Astra-Zeneca, Eli Lilly, GSK, Pfizer, and Wyeth. He has served on advisory boards for GSK, Janssen, and Sage Therapeutics. He has never served as a consultant to any biomedical or pharmaceutical corporations. Neither he nor family members have ever held equity positions in biomedical or pharmaceutical corporations.
Dr. Nemeroff has received research support from the National Institutes of Health (NIH) and Stanley Medical Research Institute. He has served on scientific advisory boards for the American Foundation for Suicide Prevention (AFSP), Anxiety and Depression Association of America (ADAA), Bracket (Clintara), Brain and Behavior Research Foundation, Laureate Institute for Brain Research (LIBR), Skyland Trail, and Xhale, on the board of directors for AFSP, ADAA, and Gratitude America, and as a consultant (within the last 3 years) to Bracket (Clintara), Fortress Biotech, Intra-Cellular Therapies Inc., Janssen Research & Development LLC, Magstim Inc., Navitor Pharmaceuticals, Sumitomo Dainippon Pharma, Sunovion Pharmaceuticals, Taisho Pharmaceutical Inc., Takeda Pharmaceuticals, TC MSO Inc., and Xhale. He has stock holdings with Abbvie, Antares, BI Gen Holdings Inc., Celgene, Corcept Therapeutics Pharmaceuticals Company, OPKO Health Inc., Seattle Genetics, and Xhale. He has received honoraria, royalties, and expert witness fees from various sources. His income sources or equity of $10,000 or more include American Psychiatric Publishing, Bracket (Clintara), CME Outfitters, Intra-Cellular Therapies Inc., Magstim, Takeda Pharmaceuticals, and Xhale. He holds patents for Method and devices for transdermal delivery of lithium (US 6,375,990B1), method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2), and Compounds, Compositions, Methods of Synthesis, and Methods of Treatment (CRF Receptor Binding Ligand) (US 8,551, 996 B2).
Human and animal rights and informed consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Butchart A, Mikton C. Global status report on violence prevention, 2014. 2014.Google Scholar
- 2.Child abuse and neglect fatalities 2016: Statistics and interventions. Washington, DC: U.S. Department of Health & Human Services AfCaF2018.Google Scholar
- 4.Anda RF, Felitti VJ, Bremner JD, Walker JD, Whitfield C, Perry BD, et al. The enduring effects of abuse and related adverse experiences in childhood. Eur Arch Psy Clin N N. 2006;256:174–86.Google Scholar
- 7.Nemeroff CB. Neurobiological consequences of childhood trauma. J Clin Psychiat. 2004;65(Suppl 1):18–28.Google Scholar
- 8.Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrino. 2008;33:693–710.Google Scholar
- 10.Meltzer-Brody S, Boschloo L, Jones I, Sullivan PF, Penninx BW. The EPDS-Lifetime: assessment of lifetime prevalence and risk factors for perinatal depression in a large cohort of depressed women. Arch Women Ment Hlth. 2013;16:465–73.Google Scholar
- 14.Dief AE, Sivukhina EV, Jirikowski GF. Oxytocin and stress response. Open J Endo Metab Dis. 2018;8. https://doi.org/10.4236/ojemd.2018.83010.
- 17.Rao VG, Löffler C, Battey J, Hansmann I. The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cytogenet Genome Res. 1992;61:271–3.Google Scholar
- 21.Gauquelin G, Geelen G, Louis F, Allevard A, Meunier C, Cuisinaud G, et al. Presence of vasopressin, oxytocin and neurophysin in the retina of mammals, effect of light and darkness, comparison with the neuropeptide content of the neurohypophysis and the pineal gland. Peptides. 1983;4:509–15.PubMedGoogle Scholar
- 26.• Freeman SM, Smith AL, Goodman MM, Bales KL. Selective localization of oxytocin receptors and vasopressin 1a receptors in the human brainstem. Soc Neurosci. 2017;12:113–23 This study is an important step towards development of oxytocin receptor ligands to open the door to conducting functional braining imaging studies of oxytocin activity.PubMedGoogle Scholar
- 27.Meynen G, Unmehopa U, Hofman M, Swaab D, Hoogendijk W. Hypothalamic oxytocin mRNA expression and melancholic depression. Molecular Psychiatr. 2007;12:118.Google Scholar
- 29.Smith AL, Freeman SM, Barnhart TE, Abbott DH, Ahlers EO, Kukis DL, et al. Initial investigation of three selective and potent small molecule oxytocin receptor PET ligands in New World monkeys. Bioorgan Med Chem Lett. 2016;26:3370–5.Google Scholar
- 31.Carter CS. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinol. 1998;23:779–818.Google Scholar
- 32.Van Ijzendoorn MH, Bakermans-Kranenburg MJ. A sniff of trust: meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group. Psychoneuroendocrinol. 2012;37:438–43.Google Scholar
- 33.Guastella AJ, Carson DS, Dadds MR, Mitchell PB, Cox RE. Does oxytocin influence the early detection of angry and happy faces? Psychoneuroendocrinol. 2009;34:220–5.Google Scholar
- 35.MacDonald K, MacDonald TM. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harvard Rev. Psychiat. 2010;18:1–21.Google Scholar
- 36.Cochran D, Fallon D, Hill M, Frazier JA. The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harvard Rev. Psychiat. 2013;21:219.Google Scholar
- 37.Bakermans-Kranenburg M, van Ijzendoorn M. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiat. 2013;3258.Google Scholar
- 43.Champagne F, Diorio J, Sharma S, Meaney MJ. Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors. P Natl Acad Sci USA. 2001;98:12736–41.Google Scholar
- 48.• Beery AK, McEwen LM, MacIsaac JL, Francis DD, Kobor MS. Natural variation in maternal care and cross-tissue patterns of oxytocin receptor gene methylation in rats. Horm Behav. 2016;77:42–52 This animal study demonstrates that parenting behavior produces epigenetic alterations in the oxytocin system.PubMedGoogle Scholar
- 54.• Ji H, Su W, Zhou R, Feng J, Lin Y, Zhang Y, et al. Intranasal oxytocin administration improves depression-like behaviors in adult rats that experienced neonatal maternal deprivation. Behav Pharmacol. 2016;27:689–96 This study in adult animals demonstrates that exogenous oxytocin may reverse lasting effects of early life adversity.PubMedGoogle Scholar
- 58.•• Valstad M, Alvares GA, Egknud M, Matziorinis AM, Andreassen OA, Westlye LT, et al. The correlation between central and peripheral oxytocin concentrations: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017;78:117–24 This meta-analysis offers important insights for understanding the utility and limitations of using peripheral measures of oxytocin as an index of central nervous system oxytocin activity.PubMedGoogle Scholar
- 59.Heim C, Young LJ, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol Psychiatr. 2009;14:954.Google Scholar
- 64.Fries ABW, Ziegler TE, Kurian JR, Jacoris S, Pollak SD. Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior. P Natl Acad Sci USA. 2005;102:17237–40.Google Scholar
- 65.Mizushima SG, Fujisawa TX, Takiguchi S, Kumazaki H, Tanaka S, Tomoda A. Effect of the nature of subsequent environment on oxytocin and cortisol secretion in maltreated children. Front Psychiatr. 2015;6:173.Google Scholar
- 66.•• Julian MM, Rosenblum KL, Doom JR, Leung CY, Lumeng JC, Cruz MG, et al. Oxytocin and parenting behavior among impoverished mothers with low vs. high early life stress. Arch Women Ment Hlth. 2018;21:375–82 This study suggests that the role of oxytocin in maternal parenting behavior may be altered in those with a previous history of childhood trauma.Google Scholar
- 70.Scantamburlo G, Hansenne M, Fuchs S, Pitchot W, Marechal P, Pequeux C, et al. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinol. 2007;32:407–10.Google Scholar
- 71.Parker KJ, Kenna HA, Zeitzer JM, Keller J, Blasey CM, Amico JA, et al. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiat Res. 2010;178:359–62.Google Scholar
- 73.Striepens N, Kendrick KM, Hanking V, Landgraf R, Wüllner U, Maier W, et al. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep-UK. 2013;3:3440.Google Scholar
- 74.Talegaonkar S, Mishra P. Intranasal delivery: an approach to bypass the blood brain barrier. Indian J Pharmacol. 2004;36:140.Google Scholar
- 84.Naber F, van Ijzendoorn MH, Deschamps P, van Engeland H, Bakermans-Kranenburg MJ. Intranasal oxytocin increases fathers’ observed responsiveness during play with their children: a double-blind within-subject experiment. Psychoneuroendocrinol. 2010;35:1583–6.Google Scholar
- 86.Mah BL, van Ijzendoorn MH, Smith R, Bakermans-Kranenburg MJ. Oxytocin in postnatally depressed mothers: its influence on mood and expressed emotion. Progr Neuro-Psychopharmacol Biol Psychiat. 2013;40:267–72.Google Scholar
- 89.•• Smearman EL, Almli LM, Conneely KN, Brody GH, Sales JM, Bradley B, et al. Oxytocin receptor genetic and epigenetic variations: association with child abuse and adult psychiatric symptoms. Child Dev. 2016;87:122–34 This study of oxytocin receptor gene DNA methylation suggests that oxytocin-related epigenetic changes may underlie the association between child abuse history and adult psychiatric illness.PubMedPubMedCentralGoogle Scholar
- 91.Thompson SM, Hammen C, Starr LR, Najman JM. Oxytocin receptor gene polymorphism (rs53576) moderates the intergenerational transmission of depression. Psychoneuroendocrinol. 2014;43:11–9.Google Scholar
- 96.Bradley B, Westen D, Mercer KB, Binder EB, Jovanovic T, Crain D, et al. Association between childhood maltreatment and adult emotional dysregulation in a low-income, urban, African American sample: moderation by the oxytocin receptor gene. Dev Psychopathol. 2011;23:439–52.PubMedPubMedCentralGoogle Scholar
- 101.Tollenaar MS, Molendijk ML, Penninx BW, Milaneschi Y, Antypa N. The association of childhood maltreatment with depression and anxiety is not moderated by the oxytocin receptor gene. Eur Arch Psy Clin N. 2017;267:517–26.Google Scholar
- 102.Myers AJ, Williams L, McAuley-Clark EZ, Dobson-Stone C, Schofield PR, Nemeroff CB. Variation in the oxytocin receptor gene is associated with increased risk for anxiety, stress and depression in individuals with a history of exposure to early life stress. J Psychiatr Res. 2014;59:93–100.PubMedPubMedCentralGoogle Scholar
- 103.Cammack AL, Hogue CJ, Drews-Botsch CD, Kramer MR, Pearce BD, Knight B, et al. An exploratory study of whether pregnancy outcomes influence maternal self-reported history of child maltreatment. Child Abuse Negl. 2018. https://doi.org/10.1016/j.chiabu.2018.01.022.
- 104.•• Toepfer P, Heim C, Entringer S, Binder E, Wadhwa P, Buss C. Oxytocin pathways in the intergenerational transmission of maternal early life stress. Neurosci Biobehav Rev. 2017;73:293–308 This excellent review examines several biological pathways, including oxytocin, pertinent to the parent-to-child transmission of vulnerability due to early life adversity.PubMedGoogle Scholar